Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mRNA
Biotech
FDA accepts filing for Moderna flu vaccine after swift rethink
The FDA has accepted Moderna’s revised influenza vaccine filing, putting the biotech on track to win approval before the 2026-27 flu season.
Nick Paul Taylor
Feb 18, 2026 9:21am
Fierce Pharma
Vaccine makers facing increased volatility, uncertainty at FDA
Feb 13, 2026 11:12am
Moderna hit with FDA refusal-to-file letter for mRNA flu shot
Feb 10, 2026 7:45pm
GSK won't pick up Wave's genetic disease RNA editor
Feb 2, 2026 11:14am
Moderna's latest CMO steps down after barely a year
Jan 30, 2026 10:58am
Moderna offloads late-stage rare disease drug for $50M upfront
Jan 30, 2026 4:14am
